Yong Zhu PhD

Associate Professor of Epidemiology (Environmental Health)

Biographical Info

Dr. Yong Zhu is an Associate Professor at Yale University School of Public Health and a co-leader of the Cancer Prevention and Control Program at Yale Cancer Center. Dr. Zhu's research interests are oriented towards the use of the molecular epidemiological approach in the study of genetic susceptibility biomarkers and their interactions with environmental exposures in human disease development. Dr. Zhu has been developing and validating novel phenotypic and genotypic assays and biomarkers for several cancer types, including non-Hodgkin's Lymphoma, breast, bladder, lung and prostate cancer. By utilizing various techniques in genetics, epigenetics, cytogenetics, cell biology, and computational biology, my studies have identified biomarkers that can characterize inherited predisposition and cellular response to environmental factors. Current research focuses on studying the role of two transcriptional factors, circadian genes and microRNAs, in tumorigenesis.

International Activity

  • Circadian disruption, circadian genes and human cancers

Education & Training

Rice University (1998)
Rice University (2000)
Postdoctoral Fellow
MD Anderson Cancer Center, Department of Epidemiology (2000 - 2002)

Honors & Recognition

  • Scholar-in Trainee Award, American Association for Cancer Research
  • Bristol-Myers Squibb Award in Clinic/Translational Research

Professional Service

  • Member, NIEHS Superfund Basic Research and Training Program Special Emphasis Panel (2009 - now)
  • Member, National Cancer Institute Study Section for Cancer Prevention Research (2008 - now)
  • Grant Reviewer, UK Medical Research Council (2008)
  • Grant Reviewer, British Council (2008)
  • Member, Pennsylvania Department of Health Special Review Panel (2007 - now)
  • Member, Health Research Board Ireland Special Review Panel for Cancer Biomarker Research Network (2006)
  • Member, Thomes F & Miller Jeffress Memorial Trust Special Review Panel (2005 - now)
  • Member, National Cancer Institute Special Review Panel for NCI-E GRB-F (2004)

Edit Profile